AC
Albion Capital Group
Venture CapitalActiveAlbion Capital Group is an independent investment manager with a long-term record of backing change and growth.
58
Investments
7
Exits
$750M
AUM
12.1%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Albion Capital Group.
Investment Thesis & Strategy
Albion Capital Group invests across various stages in fintech and venture capital, seeking companies with high growth potential and the ability to drive significant change.
Investment Activity
Deals per year over the last 15 years
3
20070
20080
20093
20100
20110
20121
20130
20141
20152
20160
20170
20180
20190
20202
2021Portfolio Companies
Selected investments from their portfolio of 58 companies
Q
Quantinuum
Other · Growth, 2021
D
DeepCura
Healthcare · Series A, 2021
T
Touchlight
Biotech · Series A, 2016
C
Congenica
Biotech · Series B, 2016
R
Reaction Engines
Other · Growth, 2015
O
Oxford Genetics
Biotech · Series A, 2013
A
Abcodia
Biotech · Series A, 2010
P
Proximagen
Biotech · Series A, 2010
A
Adaptimmune Therapeutics
Biotech · Series A, 2010
H
Horizon Discovery
Biotech · Growth, 2007
e
e-Therapeutics
Biotech · Growth, 2007
I
Immunocore
Biotech · Growth, 2007
Notable Exits
CompanyTypeYearValue / Acquirer
QuantinuumAcquisition2024—
Oxford NanoporeIPO2021$3.4B
Summit TherapeuticsIPO2015—
AbzenaIPO2014—
Horizon Discovery GroupIPO2014—
ImmunocoreAcquisition2013—
e2v technologiesIPO2006—
Frequently Asked Questions
Albion Capital Group focuses on Series A, Series B, Series C+ stage investments.